Carl Zeiss Meditec AG: Goldman Sachs voting rights notification
The Goldman Sachs Group, Inc. has reduced its total voting rights in Carl Zeiss Meditec AG to 5.54% from 5.70%. The threshold was crossed on September 30, 2026.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results.
The Goldman Sachs Group, Inc. has reduced its total voting rights in Carl Zeiss Meditec AG to 5.54% from 5.70%. The threshold was crossed on September 30, 2026.
Goldman Sachs increased its voting rights in Carl Zeiss Meditec AG to 5.70% from 5.02% as of Sept. 29. The change is due to an acquisition of shares with voting rights.
Goldman Sachs Group said its total position in Carl Zeiss Meditec rose to 5.02% from 4.83% on Sept. 23, 2026. The stake includes 0.54% of voting rights attached to shares and 4.48% through instruments.